We are entering a new era of obesity care where patients want individualized treatment plans that address their needs and provide choices, including oral formulations, said Anna Windle, PhD, Senior Vice President, Clinical Development, Medical & Regulatory Affairs at Novo Nordisk Inc, in a May 2, 2025, statement
In contrast, CB-839 showed no antitumor activity in PDAC mouse models due to the use of alternative metabolic pathways (e.g., fatty acid and lipid metabolism) by these cancer cells 45
Significant weight loss in patients with DM using GLP-1 agonist medications (GLP-1s) was observed
It is noninvasive, so it is a great solution if you have stubborn fat but dont want to have surgery
Don't skip it
When you stop taking either drug, your blood sugar may rise and you may gain weight